Hepatic progenitor cells express SerpinB3

BMC Cell Biology

Patrizia Pontisso⁴  Angelo Gatta⁴  Paolo Bernardi²  Domenico Alvaro³  Maurizio Parola¹  Claudia Paternostro¹  Rossella Semeraro³  Liliana Terrin⁴  Francesco Ciscato⁴  Mariagrazia Ruvoletto⁴  Santina Quarta⁴  Cristian Turato⁴  Gianmarco Villano⁴ 

[1] Department of Experimental Medicine and Oncology and Interuniversity Center for Liver Pathophysiology, University of Torino, Corso Raffaello 30, Torino 10125, Italy;Department of Biomedical Sciences, University of Padua, Viale Colombo 3, Padua 35131, Italy;Division of Gastroenterology, Department of Scienze e Biotecnologie Medico-Chirurgiche, Fondazione Eleonora Lorillard Spencer Cenci, University Sapienza, Rome, Viale dell’Università 37, Rome 00185, Italy;Department of Medicine-DIMED, University of Padua, Via Giustiniani 2, Padua 35128, Italy

关键词: LPS/D-Galactosamine;    Mouse model;    SerpinB3;    C57BL/6J mouse;    Hepatic progenitor cells;   

Others  :  854996
DOI  :  10.1186/1471-2121-15-5

 received in 2013-04-06, accepted in 2013-10-31,  发布年份 2014

【 摘 要 】

Background

In the setting of liver injury hepatic progenitor cells are activated, counterbalancing the inhibited regenerative capacity of mature hepatocytes. Chronic activation of this compartment may give rise to a subset of liver tumours with poor prognosis. SerpinB3, a serpin over-expressed in injured liver and in primary liver cancer, has been shown to induce apoptosis resistance, epithelial to mesenchymal transition and to increase TGF-beta and Myc expression. Aim of the present study was to explore the presence of SerpinB3 in hepatic progenitor cells in human livers and in a mouse model of liver stem/progenitor cell activation.

Hepatic progenitor cells were analysed in foetal and adult livers at protein and transcriptional levels. To induce experimental activation of the liver stem/progenitor compartment, C57BL/6J mice were injected with lipopolysaccharide plus D-galactosamine and were sacrificed at different time points. Liver cDNA was amplified using specific primers for mouse-homologous SerpinB3 isoforms and automatically sequenced.

Results

The presence of SerpinB3 in the progenitor cell compartment was detected in sorted human foetal and adult epithelial cell adhesion molecule (EpCAM) positive liver cells. By immunohistochemistry SerpinB3 was found in human cirrhotic livers in portal areas with progenitor cell activation showing ductular proliferation. CK-7, CK-19, EpCAM and CD-90 positive cell were also positive for SerpinB3. In the animal model, time course analysis in liver specimens revealed a progressive increase of SerpinB3 and a parallel decrease of activated caspase 3, which was barely detectable at 20 hours. Transcription analysis confirmed the presence of SerpinB3-homologous only in the liver of injured mice and sequence analysis proved its belonging to mouse Serpinb3b.

Conclusion

SerpinB3 is highly expressed in hepatic stem/progenitor cell compartment of both foetal and adult livers.

【 授权许可】

   
2014 Villano et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Fausto N: Liver regeneration and repair: hepatocytes, progenitor cells and stem cells. Hepatology 2004, 39:477-487.
• [2]Roskams T: Different types of liver progenitor cells and their niches. J Hepatol 2006, 45:1-4.
• [3]Kordes C, Häussinger D: Hepatic stem cell niches. J Clin Invest 2013, 123:1874-1880.
• [4]Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, Brunt EM, Crawford JM, Crosby HA, Desmet V, Finegold MJ, Geller SA, Gouw AS, Hytiroglou P, Knisely AS, Kojiro M, Lefkowitch JH, Nakanuma Y, Olynyk JK, Park YN, Portmann B, Saxena R, Scheuer PJ, Strain AJ, Thung SN, Wanless IR, West AB: Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004, 39:1739-1745.
• [5]Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS: A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006, 12:410-416.
• [6]Silverman GA, Whisstock JC, Askew DJ, Pak SC, Luke CJ, Cataltepe S, Irving JA, Bird PI: Human clade B serpins (ov-serpins) belong to a cohort of evolutionary dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell Mol Life Sci 2004, 61:301-325.
• [7]Turato C, Buendia MA, Fabre M, Redon MJ, Branchereau S, Quarta S, Ruvoletto M, Perilongo G, Grotzer MA, Gatta A, Pontisso P: Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour? Eur J Cancer 2012, 48:1219-1226.
• [8]Turato C, Calabrese F, Biasiolo A, Quarta S, Ruvoletto M, Tono N, Paccagnella D, Fassina G, Merkel C, Harrison TJ, Gatta A, Pontisso P: SERPINB3 modulates TGF-beta expression in chronic liver disease. Lab Invest 2010, 90:1016-1023.
• [9]Guido M, Roskams T, Pontisso P, Fassan M, Thung SN, Giacomelli L, Sergio A, Farinati F, Cillo U, Rugge M: Squamous cell carcinoma antigen in human liver carcinogenesis. J Clin Pathol 2008, 61:445-447.
• [10]Giannelli G, Marinosci F, Sgarra C, Lupo L, Dentico P, Antonaci S: Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma. Int J Cancer 2005, 116:579-583.
• [11]Pontisso P, Calabrese F, Benvegnù L, Lise M, Belluco C, Ruvoletto MG, Marino M, Valente M, Nitti D, Gatta A, Fassina G: Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer 2004, 90:833-837.
• [12]Vidalino L, Doria A, Quarta S, Zen M, Gatta A, Pontisso P: SERPINB3, apoptosis and autoimmunity. Autoimmunity Rev 2009, 9:108-112.
• [13]Suminami Y, Nagashima S, Vujanovic NL, Hirabayashi K, Kato H, Whiteside TL: Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br J Cancer 2000, 82:981-989.
• [14]Quarta S, Vidalino L, Turato C, Ruvoletto M, Calabrese F, Valente M, Cannito S, Fassina G, Parola M, Gatta A, Pontisso P: SERPINB3 induces epithelial to mesenchymal transition. J Pathol 2010, 221:343-356.
• [15]Schneider SS, Schick C, Fish KE, Miller E, Pena JC, Treter SD, Hui SM, Silverman GA: A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci U S A 1995, 92:3147-3151.
• [16]Askew DJ, Askew YS, Kato Y, Turner RF, Dewar K, Lehoczky J, Silverman GA: Comparative genomic analysis of the clade B serpin cluster at human chromosome 18q21: amplification within the mouse squamous cell carcinoma antigen gene locus. Genomics 2004, 84:176-184.
• [17]Nowak M, Gaines GC, Rosenberg J, Minter R, Bahjat FR, Rectenwald J, MacKay SL, Edwards CK 3rd, Moldawer LL: LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor. Am J Physiol Regul Integr Comp Physiol 2000, 278:R1202-R1209.
• [18]Sell S, Leffert HL: Liver cancer stem cells. J Clin Oncol 2008, 26:2800-2805.
• [19]Shibuya M, Kondo F, Sano K, Takada T, Asano T: Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2011, 18:537-543.
• [20]Libbrecht L, Roskams T: Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol 2002, 13:389-396.
• [21]Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, Lesaffre E, Libbrecht L, Desmet V, Roskams T: The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma, a possible progenitor cell origin. Histopathology 2006, 49:138-151.
• [22]Yoon SM, Gerasimidou D, Kuwahara R, Hytiroglou P, Yoo JE, Park YN, Theise ND: Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology 2011, 53:964-973.
• [23]Novo E, Busletta C, Bonzo LV, Povero D, Paternostro C, Mareschi K, Ferrero I, David E, Bertolani C, Caligiuri A, Cannito S, Tamagno E, Compagnone A, Colombatto S, Marra F, Fagioli F, Pinzani M, Parola M: Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. J Hepatol 2011, 54:964-974.
• [24]Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao HL, Moss N, Melhem A, McClelland R, Turner W, Kulik M, Sherwood S, Tallheden T, Cheng N, Furth ME, Reid LM: Human hepatic stem cells from fetal and postnatal donors. J Exp Med 2007, 204:1973-1987.
• [25]Cardinale V, Wang Y, Carpino G, Cui CB, Gatto M, Rossi M, Berloco PB, Cantafora A, Wauthier E, Furth ME, Inverardi L, Dominguez-Bendala J, Ricordi C, Gerber D, Gaudio E, Alvaro D, Reid L: Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes and pancreatic islets. Hepatology 2011, 54:2159-2172.
• [26]Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
• [27]Villano G, Quarta S, Ruvoletto MG, Turato C, Vidalino L, Biasiolo A, Tono N, Lunardi F, Calabrese F, Dall’Olmo L, Dedja A, Fassina G, Gatta A, Pontisso P: Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. Int J Mol Med 2010, 25:137-143.
• [28]Sakata Y, Arima K, Takeshita K, Takai T, Aoki S, Ogawa H, Sugihara H, Fujimoto K, Izuhara K: Characterization of novel squamous cell carcinoma antigen-related molecules in mice. Biochem Biophys Res Commun 2004, 324:1340-1345.
• [29]Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
• [30]Yuan H, Li L, Zheng W, Wan J, Ge P, Li H, Zhang L: Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice. Int Immunopharmacol 2012, 12:682-688.
• [31]Evarts RP, Hu Z, Omori N, Omori M, Marsden ER, Thorgeirsson SS: Precursor-product relationship between oval cells and hepatocytes: comparison between tritiated thymidine and bromodeoxyuridine as tracers. Carcinogenesis 1996, 17:2143-2151.
• [32]Alison M: Liver stem cells: a two compartment system. Curr Opin Cell Biol 1998, 10:710-715.
• [33]Roskams T: Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus. J Hepatol 2003, 39:431-434.
• [34]Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, Bussolati B, Camussi G: Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006, 24:2840-2850.
• [35]Dan YY, Riehle KJ, Lazaro C, Teoh N, Haque J, Campbell JS, Fausto N: Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci U S A 2006, 103:9912-9917.
• [36]Cardinale V, Wang Y, Carpino G, Mendel G, Alpini G, Gaudio E, Reid LM, Alvaro D: The biliary tree–a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol 2012, 9:231-240.
• [37]Turner R, Lozoya O, Wang Y, Cardinale V, Gaudio E, Alpini G, Mendel G, Wauthier E, Barbier C, Alvaro D, Reid LM: Human hepatic stem cell and maturational liver lineage biology. Hepatology 2011, 53:1035-1045.
• [38]Galanos C, Freudenberg MA, Reutter W: Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A 1979, 76:5939-5943.
• [39]Jiang W, Sun R, Wei H, Tian Z: Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proc Natl Acad Sci U S A 2005, 102:17077-17082.
• [40]Martich GD, Danner RL, Ceska M, Suffredini AF: Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J Exp Med 1991, 173:1021-1024.
• [41]Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995, 146:1220-1223.
• [42]Nguyen LN, Furuya MH, Wolfraim LA, Nguyen AP, Holdren MS, Campbell JS, Knight B, Yeoh GC, Fausto N, Parks WT: Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology 2007, 45:31-41.
• [43]Vidalino L, Doria A, Quarta SM, Crescenzi M, Ruvoletto M, Frezzato F, Trentin L, Turato C, Parolin M, Ghirardello A, Iaccarino L, Cavalletto L, Chemello L, Gatta A, Pontisso P: SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection. Exp Biol Med 2012, 237:793-802.
• [44]Al-Khunaizi M, Luke CJ, Askew YS, Pak SC, Askew DJ, Cataltepe S, Miller D, Mills DR, Tsu C, Brömme D, Irving JA, Whisstock JC, Silverman GA: The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. Biochemistry 2002, 41:3189-3199.
• [45]Wu K, Ding J, Chen C, Sun W, Ning BF, Wen W, Huang L, Han T, Yang W, Wang C, Li Z, Wu MC, Feng GS, Xie WF, Wang HY: Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Hepatology 2012, 56:2255-2267.